Call for Abstract

Annual Pharmacy and Pharmaceutical Science Conference, will be organized around the theme “Global Innovations & Recent Advancements in Pharmaceutical Science”

Pharma Conference 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharma Conference 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Drug discovery and development together are the complete process of identifying a new drug and bringing it to market. Discovery may involve screening of chemical libraries, identification of the active ingredient from a natural remedy or design resulting from an understanding of the target. Development includes studies on microorganisms and animals, clinical trials and ultimately regulatory approval. The process of drug discovery involves a combination of many disciplines and interests starting from a simple process of identifying an active compound. The discovery of a new chemical entity that modifies a cell or tissue function is but the first step in the drug development process. Once shown to be effective and selective, a compound which is to be discovered must be completely free of toxicity, should have good bioavailability and marketable before it can be considered to be a therapeutic entity.

  • Track 1-1Drug target
  • Track 1-2Clinical Research
  • Track 1-3Computer-aided drug design
  • Track 1-4Ligand-based drug design
  • Track 1-5Genotoxicity studies

Drug delivery is the process of administering the drug or pharmaceutical product, in order to achieve desired therapeutic effect. The method by which drug delivered is important, as it has significant effect on its efficacy. Novel drug delivery system involves various approaches like medical devices or drug-device combination products. NDDS involves combining pharmaceutics polymer science, and molecular biology. Novel drug delivery systems are designed based on physical and biochemical mechanisms. Physical mechanism or controlled drug delivery system includes dissolution, osmosis, erosion and diffusion. Biochemical mechanism includes gene therapy, liposomes, nanoparticles, monoclonal antibodies. NDDS we can make ideal drugs, controlled delivery, selective targeting at site of action. Various drug delivery and drug targeted systems are developed, in order to minimize drug degradation, drug adverse effect, and in order to increase the drug bioavailability (amount of drug available at site targeted region).  

  • Track 2-1 Matrix Diffusion Types
  • Track 2-2Drug loaded erythrocytes
  • Track 2-3Osmotic Pressure Controlled
  • Track 2-4Chemically controlled
  • Track 2-5Hydrogels

Nanotechnology is a study related to nanosized particles, their function and practice with respect to different systems. The role of nanotechnology in the field of pharmaceutics has exceptionally altered the way of our understanding about drugs, nanodrugs or the use of nanoparticles as carrier of drug has become the basic fundamental or criteria for the production or design of a drug. Pharmaceutical nanotechnology is appliance of nanoscience to pharmaceuticals as nanomaterials, and devices like diagnostic,drug delivery, biosensor, and imaging . Pharmaceutical nanotechnology has tuned diagnosis and focused treatment of disease at  a molecular level.  Nanotechnology is highly specialized field, which will revolutionize the pharmaceutical industry.

  • Track 3-1Nanomaterials
  • Track 3-2 Drug carrier system
  • Track 3-3Molecular Diagnostics
  • Track 3-4Biosensor and biolabels

Bioavailability and bioequivalence studies play a important role during the drug development for both new drugs and generic drugs and thus have gained great attention over the past few decades. Bioavailability is the rate and extent to which the active moeity or is absorbed from the dosage form and is available at the required site of action. Relative bioavailability of drug after administered orally is compared with that of an oral standard of the same drug aqueous or non-aqueous solutions.  Absolute bioavailability It compares the bioavailability of the active drug administered through non intravenous routes such as after transdermal route, oral route, rectal route, sublingual route , subcutaneous route,  of administration and comparing the bioavailability of the same drug administered intravenously.

Bioequivalence studies are as vital concern in drug development process, which are required for small changes in drug products that develop during drug development to ensure that the dosage forms prove to be safe and effective. Moreover, bioequivalence has proven even more significant in case of drugs with narrow therapeutic index.

  • Track 4-1First Pass Metabolism
  • Track 4-2Relative Bioavailability
  • Track 4-3Absolute Bioavailability
  • Track 4-4Therapeutic relevance
  • Track 4-5Pka and Pkd Models

Pharmacogenomics (constitute both branch i.e. pharmacology and genetic) is the study of the role of genetics in drug response. It deals with the effect of genetic variation on drug response in patient by correlating the gene expression with the pharmacokinetic parameter i.e. absorption, distribution metabolism and excretions. The Pharmacogenomics is used in the research to increase the safety and efficacy of the drug by targeting the drug at the particular site of genes. Pharmacogenetics also play important role in the study of effect of multiple genes in the pharmacological action of drugs.  Most of the drugs fail to show therapeutic effect at the latter stages it may be due to unexpected adverse effect of drug that may be due to the effect of various component of genes. Pharmacogenetics studies can be used at various stages of drug development. In clinical studies, pharmacogenetics can be used in stratification of patient based on their genotype, which correspond to their metabolizing capacity. This helps in prevention of various adverse drug reaction and better outcomes of clinical trials.

  • Track 5-1Toxicogenomics
  • Track 5-2Toxicogenomics
  • Track 5-3Pharmacoproteomics
  • Track 5-4Clinical Pharmacogenomics
  • Track 5-5Gene Polymorphism

Pharmaceutical formulation is a part of the drug development procedure. In this process Active ingredient is formulated into a final dosage form using proper excipients and Technological procedures. A drug can have many forms depending upon how it is manufactured, route to be taken or the desired effects. The most common forms of drugs are tablets, capsules or solutions. Drug Formulation include Novel dosage forms, like tablets, sterile products, capsules,  topical preparations, sustained-release and controlled release. 

  • Track 6-1Parenteral Dosage Forms
  • Track 6-2Topical and Transdermal Delivery
  • Track 6-3Ophthalmic Dosage Forms
  • Track 6-4Inhalation Dosage Forms
  • Track 6-5Oral Solid Dosage Forms

Clinical trials are medical research studies involving people. They aim to test whether different treatments are safe and how well they work. Some trials involve healthy members of the public. Others involve patients who may be offered the option of taking part in a trial during their care and treatment. Clinical trials are carried out to try to answer specific questions about health and illness. Clinical trial is a systematic investigation in human subjects for evaluating the safety & efficacy of any new drug. Clinical trials are a set of tests in medical research and drug development that generate safety and efficacy data for health interventions in human beings.  

Four phases of clinical trials and medicine development exist and are defined below.

Phase1: It is the first stage and usually involves small groups of healthy people or sometimes patients. Phase 1 trials are mainly aimed at finding out how safe a drug

Phase2: Objectives focus on dose-response, type of patient, frequency of dosing, or numerous other characteristics of safety and efficacy.

Phase3: clinical trials generate data on both safety and efficacy in relatively large numbers of patients in both controlled and uncontrolled trials.

Phase4:  Trials conducted after a medicine is marketed to provide additional details about the medicine's efficacy or safety profile. Different formulations, dosages, durations of treatment, medicine interactions, and other medicine comparisons may be evaluated.

  • Track 7-1Preclinical trails
  • Track 7-2Phases of clinical trails
  • Track 7-3Optimum dose finding
  • Track 7-4Single ascending dose limits
  • Track 7-5Multiple ascending dose limits

Packaging is the science, art and technology of enclosing or protecting products for Distribution, storage, sale and use. A final product is not accepted except it is properly packaged, and in some cases the major part of the formulation process may be concerned with selecting the correct package for the product. Packaging also refers to the process of design, evaluation and fabrication of packages.

Advances in Packaging System

Blow- fill- seal technology was initially used for filling many categories of liquids, such as non-sterile devices, foods and cosmetics. Recently, Blow- fill- seal technology is used to produce aseptically sterile pharmaceuticals such as respiratory solutions, ophthalmics, and wound care products.

Induction Cup sealing technology is used to create airtight and hermetic seals on the neck of the container.  The process of Induction cup sealing is based on the principle that a conductive material like aluminum foil heats up on exposure to high frequency magnetic field generated by an induction unit.

Tamper Evident Pharmaceutical Packaging can be defined as Packaging having an indicator or barrier to entry which, if breached or missing, can reasonably be expected to provide visible or audible evidence to consumers that tampering has occurred. Tamper-evident packaging involves immediate-container/carton systems or any combination.

Novel Laser Coding Technology for Pharmaceutical Glass Containers Glass syringes can now be individually coded / safe process free of micro-cracks / Reliable Track & Trace. A completely new laser-coding system enables glass containers for parenteral use to be clearly coded at the glass syringe manufacturer and tracked from production to end customer

  • Track 8-1Film wrappers
  • Track 8-2Blister package
  • Track 8-3Strip package
  • Track 8-4Bubble pack
  • Track 8-5Shrink seal and bands

The pharmaceutical analysis is a branch of chemistry, which deals with determination of the quality and quantity of the pharmaceutical products. It is used for the separation of chemical components from the mixture and for the determination of the structure of the compounds. Analysis plays a vital role in the pharmacy. There are various methods for separation, identification and purification of chemical components by using Chromatography method, High performance liquid chromatography, Gas chromatography, Liquid chromatography, UV spectrometry, Mass Spectrometry.

  • Track 9-1Titration Methods
  • Track 9-2Quality Control
  • Track 9-3UV Spectrometry
  • Track 9-4Spectroscopic Techniques
  • Track 9-5Chromatographic Techniques

Quality assurance is to prevent defects in deliverables in the planning process itself to avoid the rework, which cost a lot. Quality assurance is a proactive process, and it starts at the early stage of the project to understand the product stated and non-stated requirement and expectations, and then develop the plan to meet these requirements and expectations. Quality control is concerned with the operational activites and techniques that are used to fulfill the requirements of quality. The quality control process includes the activities focus on identifying defects in the actual product being produced.

  • Track 10-1Good Manufacturing Practice
  • Track 10-2Analytical Techniques
  • Track 10-3Sample handlings
  • Track 10-4Calibration Procedures
  • Track 10-5sampling and Analysis plan

Pharmacokinetics is study of absorption, distribution, metabolism and excretion of a drug, and pharmacodynamics is the study of relationship between the drug and its receptors, its mechanism of action and therapeutic effect. Both can play a role in drug–drug interactions. Many drugs share the same metabolic pathways or target the same receptors. This leads to the occurrence of pharmacokinetic and pharmacodynamic differences, respectively. Drug–drug interactions occur mainly during drug absorption, distribution (plasma drug binding protein), biotransformation and excretion.

  • Track 11-1Thereapeutic window
  • Track 11-2Area Under Curve
  • Track 11-3Biopharmaceuticals Process Validation
  • Track 11-4Drug Metabolism
  • Track 11-5Pka and Pkd Models

Pharmacology is the science of drugs, it deals with the interaction of externally administered chemical entity (drugs) with living systems. It encircles all aspects of knowledge about drugs, but most essentially those that are relevant to effective and safe use for medicinal purposes. Toxicology is the study of the poisonous effect of drugs and other chemicals (household, the environmental pollutant, industrial, agricultural, homicidal) with emphasis on detection, prevention, and treatment of poisonings. It also includes the study of adverse effects of drugs, since the same substance can be a drug or a poison, depending on the dose.

  • Track 12-1Neuro pharmacology
  • Track 12-2Pharmacognosy
  • Track 12-3Clinical toxicology
  • Track 12-4Receptors
  • Track 12-5Adverse Drug Reactions

Target drug delivery system is a special form of drug delivery system where the pharmacologically active agent or medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells. Targeted drug delivery implies for selective and effective localization of pharmacologically active moiety at pre identified (preselected) target in therapeutic concentration, while restricting its access to non-target normal cellular linings, thus minimizing toxic effects and maximizing therapeutic index. Targeting of drugs to special cells and tissues of the body without their becoming a part of systemic circulation is a very novel idea. A drug can be administered in a form such that it reaches the receptor sites in sufficient concentration without disturbing the extraneous tissue cells.

  • Track 13-1Passive Targeting
  • Track 13-2Inverse Targeting
  • Track 13-3Ligand Mediated Targeting
  • Track 13-4Liposomes
  • Track 13-5Nano Tubes

Pharmacovigilance is “the science and activities relating to the assessment, understanding, detection, and prevention of adverse effects or any other drug-related problems.” Pharmacovigilance is the process and science of controlling the safety of medicines and taking action to decrease risks and increase benefits from medicines. It provides complete and clear information related to drug safety and various risks and benefits associated with them. Pharmacovigilance can help in providing information of unintended and severe adverse events which could not be provided by clinical trials involving in-vivo method. It increases the impact of pharmacovigilance on patient welfare and public health and to know what is pharmacovigilance.

  • Track 14-1Detection And Evaluation Of Drug Safety
  • Track 14-2Pharmacovigilance Legislation
  • Track 14-3Pharmacovigilance And Healthcare System
  • Track 14-4Methods Of Pharmacovigilance

Regulatory Affairs a blend of science and administration to achieve an important objective within a drug development organization. Everything relating to drugs from the earliest non-clinical studies, through development, into routine manufacture and marketing. It can add compelling impact for patients and drug companies. The role of regulatory affairs is to establish and execute a regulatory strategy to ensure that the collective efforts of the drug development team results in a product that is approvable by global regulators but is also differentiated from the competition in some way and also is to ensure that the company’s activities, from non-clinical research through to advertising and promotion, are conducted in accordance with the regulations and guidelines established by regulatory authorities.

  • Track 15-1Good Manufacturing Practice
  • Track 15-2Regulatory Compliance
  • Track 15-3Drug Labelling Approvals
  • Track 15-4Drug Marketing Approvals
  • Track 15-5Manufacturing And Regulatory Compliance